128 related articles for article (PubMed ID: 2024099)
1. [Adjuvant therapies in breast carcinoma].
Joss R; Brunner K
Schweiz Rundsch Med Prax; 1991 Mar; 80(11):247-54. PubMed ID: 2024099
[TBL] [Abstract][Full Text] [Related]
2. [Breast carcinoma--adjuvant chemo- and hormone therapy].
Fey MF
Ther Umsch; 1998 Jul; 55(7):413-4. PubMed ID: 9702106
[TBL] [Abstract][Full Text] [Related]
3. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
[TBL] [Abstract][Full Text] [Related]
4. [Adjuvant systemic therapy in breast carcinoma in the 1990s: status of things and open questions].
Goldhirsch A; Neuenschwander H; Castiglione M; Senn HJ; Cavalli F
Schweiz Med Wochenschr; 1990 Nov; 120(47):1771-83. PubMed ID: 2255883
[TBL] [Abstract][Full Text] [Related]
5. Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy.
Gasparini G; Barbareschi M; Boracchi P; Verderio P; Caffo O; Meli S; Dalla Palma P; Marubini E; Bevilacqua P
Cancer J Sci Am; 1995; 1(2):131-41. PubMed ID: 9166466
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen versus tamoxifen + mitoxantrone treatment in metastatic breast cancer.
Kars A; Baltali E; Tekuzman G; Firat D; Alakavuklar M
J Chemother; 1989 Jul; 1(4 Suppl):1196-7. PubMed ID: 16312831
[No Abstract] [Full Text] [Related]
7. Adjuvant treatment of breast cancer.
Akerley WL
R I Med; 1995 Sep; 78(9):250-3. PubMed ID: 7579720
[No Abstract] [Full Text] [Related]
8. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
[TBL] [Abstract][Full Text] [Related]
9. National Institutes of Health Consensus Development Conference on Adjuvant Chemotherapy and Endocrine Therapy for Breast Cancer. Editorial overview.
Lippman ME; Chabner BA
NCI Monogr; 1986; (1):5-10. PubMed ID: 3534591
[No Abstract] [Full Text] [Related]
10. A prognostic table to guide practitioners advising patients on adjuvant systemic therapy in early breast cancer.
Stotter A
Eur J Surg Oncol; 1999 Aug; 25(4):341-3. PubMed ID: 10419700
[No Abstract] [Full Text] [Related]
11. Clinical trials referral resource. Adjuvant therapy of breast cancer.
Cheson BD
Oncology (Williston Park); 1989 Jun; 3(6):70-1, 74-5, 78. PubMed ID: 2534915
[No Abstract] [Full Text] [Related]
12. [Recent advance in adjuvant therapy for breast cancer].
Shimizu C; Watanabe T
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2458-69. PubMed ID: 12506467
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant therapy for node-negative breast cancer: a proactive view.
Glick JH
Important Adv Oncol; 1990; ():183-97. PubMed ID: 2182518
[No Abstract] [Full Text] [Related]
14. Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group.
Morales L; Canney P; Dyczka J; Rutgers E; Coleman R; Cufer T; Welnicka-Jaskiewicz M; Nortier J; Bogaerts J; Therasse P; Paridaens R; ;
Eur J Cancer; 2007 Jan; 43(2):331-40. PubMed ID: 17134892
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant therapy in breast cancer.
Robert NJ
Obstet Gynecol Clin North Am; 1994 Dec; 21(4):693-707. PubMed ID: 7731642
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
[TBL] [Abstract][Full Text] [Related]
17. Use of anti-oestrogen Zitazonium (tamoxifen) as adjuvant to cytostatic treatment in metastatic breast cancer.
Palka I; Jávor J
Ther Hung; 1986; 34(4):217-23. PubMed ID: 3449976
[No Abstract] [Full Text] [Related]
18. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials.
Taghian A; Jeong JH; Mamounas E; Anderson S; Bryant J; Deutsch M; Wolmark N
J Clin Oncol; 2004 Nov; 22(21):4247-54. PubMed ID: 15452182
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant systemic therapy in primary breast cancer.
Mouridsen HT; Palshof T
Acta Chir Scand Suppl; 1984; 519():43-53. PubMed ID: 6393664
[No Abstract] [Full Text] [Related]
20. [Neoadjuvant chemotherapy of patients with breast carcinoma].
Jakesz R; Taucher S; Gnant M; Gebhard B; Kandioler D; Rudas M; Djavanmard M; Steger G
Zentralbl Chir; 1998; 123 Suppl 5():147-50. PubMed ID: 10063601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
